首页 | 本学科首页   官方微博 | 高级检索  
     


Long-term retention rates of adalimumab and infliximab in non-infectious intermediate,posterior, and panuveitis
Authors:Fabiani  Claudia  Vitale  Antonio  Emmi  Giacomo  Bitossi  Alice  Lopalco  Giuseppe  Sota  Jurgen  Guerriero  Silvana  Orlando  Ida  Capozzoli  Marco  Fusco  Fiorella  Rana  Francesco  Iannone  Florenzo  Frediani  Bruno  Galeazzi  Mauro  Vannozzi  Lorenzo  Tosi  Gian Marco  Cantarini   Luca
Affiliation:1.Department of Ophthalmology, Humanitas Clinical and Research Center, Rozzano, Milan, Italy
;2.Ophthalmology Unit, Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy
;3.Research Center of Systemic Autoinflammatory Diseases, Behçet’s Disease Clinic and Rheumatology-Ophthalmology Collaborative Uveitis Center, Department of Medical Sciences, Surgery and Neurosciences, University of Siena, Siena, Italy
;4.Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy
;5.Department of Surgery and Translational Medicine, Eye Clinic, University of Florence, Florence, Italy
;6.Interdisciplinary Department of Medicine, Rheumatology Unit, University of Bari, Bari, Italy
;7.Department of Ophthalmology and Otolaryngology, University of Bari, Bari, Italy
;
Abstract:Clinical Rheumatology - The aim of the present study was to compare long-term adalimumab (ADA) and infliximab (IFX) retention rates in patients with intermediate, posterior, or panuveitis....
Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号